© 1996 American Heart Association, Inc.
Articles |
Low Whole-Blood S-Adenosylmethionine and Correlation Between 5-Methyltetrahydrofolate and Homocysteine in Coronary Artery Disease
From the Metabolic Unit, University Children's Hospital (F.M.T.L., C.P.A., B.F.); University Computer Center (P.P.J.); and the Divisions of Clinical Pharmacology (W.E.H.) and Intensive Care (R.R.), University Hospital, Basel, Switzerland.
Abstract Mild elevation of plasma homocysteine is an independent risk factor for vascular disease. We studied the role of 5-methyltetrahydrofolate (5-MTHF), the folate form directly involved in homocysteine metabolism, in contrast to previous studies, which used total folate measurements, in 70 coronary artery disease (CAD) patients and control subjects. We also measured S-adenosylmethionine (SAM), which controls the activity of critical enzymes of homocysteine metabolism. Fasting plasma total homocysteine was elevated (>12.4 µmol/L for women, >13.3 µmol/L for men) in 17% of patients, in accordance with earlier studies. These patients showed lower 5-MTHF (12.4±1.0 nmol/L, mean±SD) than control subjects (24.2±15.0, P<.001), and there was a clear correlation (multiple linear regression analysis: P=.002) of this relevant form of folate with homocysteine. However, 37% of the normohomocysteinemic patients also revealed similarly low 5-MTHF levels, suggesting that a decrease of 5-MTHF does not necessarily cause hyperhomocysteinemia. SAM was significantly decreased in patients (1.4±0.4 µmol/L) compared with control subjects (1.8±0.3, P<.001) but was not correlated to homocysteine or 5-MTHF. The correlation between homocysteine and 5-MTHF that was found in CAD patients but not in control subjects confirms the direct relationship between these compounds in vivo. The new finding of low SAM in patients demands further studies, since it might indicate that low levels pose risk and that SAM might be a protective factor against the development of CAD.
Key Words: 5-methyltetrahydrofolate • coronary artery disease • homocysteine • methylenetetrahydrofolate reductase • S-adenosylmethionine
This article has been cited by other articles:
 |
|
 |
|
  A.M.W. Spijkerman, Y.M. Smulders, P.J. Kostense, R.M.A. Henry, A. Becker, T. Teerlink, C. Jakobs, J.M. Dekker, G. Nijpels, R.J. Heine, et al. S-Adenosylmethionine and 5-Methyltetrahydrofolate Are Associated With Endothelial Function After Controlling for Confounding by Homocysteine: The Hoorn Study Arterioscler Thromb Vasc Biol, April 1, 2005; 25(4): 778 - 784. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Narayanan, J. McConnell, J. Little, L. Sharp, C. J. Piyathilake, H. Powers, G. Basten, and S. J. Duthie Associations between Two Common Variants C677T and A1298C in the Methylenetetrahydrofolate Reductase Gene and Measures of Folate Metabolism and DNA Stability (Strand Breaks, Misincorporated Uracil, and DNA Methylation Status) in Human Lymphocytes In vivo Cancer Epidemiol. Biomarkers Prev., September 1, 2004; 13(9): 1436 - 1443. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. P. Basten, M. H. Hill, S. J. Duthie, and H. J. Powers Effect of Folic Acid Supplementation on the Folate Status of Buccal Mucosa and Lymphocytes Cancer Epidemiol. Biomarkers Prev., July 1, 2004; 13(7): 1244 - 1249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Homocysteine Studies Collaboration Homocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis JAMA, October 23, 2002; 288(16): 2015 - 2022. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Suormala, G. Gamse, and B. Fowler 5,10-Methylenetetrahydrofolate Reductase (MTHFR) Assay in the Forward Direction: Residual Activity in MTHFR Deficiency Clin. Chem., June 1, 2002; 48(6): 835 - 843. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-C. Beauchamp and G. Renier Homocysteine Induces Protein Kinase C Activation and Stimulates c-Fos and Lipoprotein Lipase Expression in Macrophages Diabetes, April 1, 2002; 51(4): 1180 - 1187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. S Ford, S J. Smith, D. F Stroup, K. K Steinberg, P. W Mueller, and S. B Thacker Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies Int. J. Epidemiol., February 1, 2002; 31(1): 59 - 70. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.C. Verhaar, E. Stroes, and T.J. Rabelink Folates and Cardiovascular Disease Arterioscler Thromb Vasc Biol, January 1, 2002; 22(1): 6 - 13. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Caudill, J. C. Wang, S. Melnyk, I. P. Pogribny, S. Jernigan, M. D. Collins, J. Santos-Guzman, M. E. Swendseid, E. A. Cogger, and S. J. James Intracellular S-Adenosylhomocysteine Concentrations Predict Global DNA Hypomethylation in Tissues of Methyl-Deficient Cystathionine {beta}-Synthase Heterozygous Mice J. Nutr., November 1, 2001; 131(11): 2811 - 2818. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. L. Booth, E. E.L. Wang, and with the Canadian Task Force on Preventive Health Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events Can. Med. Assoc. J., July 1, 2000; 163(1): 21 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Melnyk, M. Pogribna, I. P. Pogribny, P. Yi, and S. J. James Measurement of Plasma and Intracellular S-Adenosylmethionine and S-Adenosylhomocysteine Utilizing Coulometric Electrochemical Detection: Alterations with Plasma Homocysteine and Pyridoxal 5'-Phosphate Concentrations Clin. Chem., February 1, 2000; 46(2): 265 - 272. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Fonseca, S. C. Guba, and L. M. Fink Hyperhomocysteinemia and the Endocrine System: Implications for Atherosclerosis and Thrombosis Endocr. Rev., October 1, 1999; 20(5): 738 - 759. [Abstract] [Full Text]
|
|
|
|
|
|
L. B. Bailey and J. F. Gregory III Polymorphisms of Methylenetetrahydrofolate Reductase and Other Enzymes: Metabolic Significance, Risks and Impact on Folate Requirement J. Nutr., May 1, 1999; 129(5): 919 - 922. [Abstract] [Full Text]
|
|
|
|
|
|
H. Morita, H. Kurihara, T. Sugiyama, C. Hamada, Y. Kurihara, T. Shindo, Y. Oh-hashi, and Y. Yazaki Polymorphism of the Methionine Synthase Gene : Association With Homocysteine Metabolism and Late-Onset Vascular Diseases in the Japanese Population Arterioscler Thromb Vasc Biol, February 1, 1999; 19(2): 298 - 302. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Malinow, A. G. Bostom, and R. M. Krauss Homocyst(e)ine, Diet, and Cardiovascular Diseases : A Statement for Healthcare Professionals From the Nutrition Committee, American Heart Association Circulation, January 12, 1999; 99(1): 178 - 182. [Full Text] [PDF]
|
|
|
|
|
|
M. C. Verhaar, R. M. F. Wever, J. J. P. Kastelein, T. van Dam, H. A. Koomans, and T. J. Rabelink 5-Methyltetrahydrofolate, the Active Form of Folic Acid, Restores Endothelial Function in Familial Hypercholesterolemia Circulation, January 27, 1998; 97(3): 237 - 241. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. M. T. Loehrer, R. Schwab, C. P. Angst, W. E. Haefeli, and B. Fowler Influence of Oral S-Adenosylmethionine on Plasma 5-Methyltetrahydrofolate, S-Adenosylhomocysteine, Homocysteine and Methionine in Healthy Humans J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 845 - 850. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. Yi, S. Melnyk, M. Pogribna, I. P. Pogribny, R. J. Hine, and S. J. James Increase in Plasma Homocysteine Associated with Parallel Increases in Plasma S-Adenosylhomocysteine and Lymphocyte DNA Hypomethylation J. Biol. Chem., September 15, 2000; 275(38): 29318 - 29323. [Abstract] [Full Text] [PDF]
|
|